Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial-Reference-Cited by-同舟云学术

Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial

Published:2015-04 Issue:4 Volume:3 Page:254-262
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Jia Weiping,Xiao Xinhua,Ji Qiuhe,Ahn Kyu-Jeung,Chuang Lee-Ming,Bao Yuqian,Pang Can,Chen Lei,Gao Fei,Tu Yinfang,Li Pengfei,Yang Jun

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference32 articles.

1. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

2. Prevalence of diabetes among men and women in China;Yang;N Engl J Med,2010

3. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts;Qiao;Diabetologia,2000

4. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus;Diabetes Care,1997

5. Prevalence of diabetes mellitus in the elderly of Namwon County, South Korea;Kim;Korean J Intern Med,2002

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges;World Journal of Diabetes;2024-05-15

2. A prospective, multicentre, randomized, open-label comparison of a long-acting basal insulin analog glargine plus glulisine with premixed insulin in insulin naïve patients with Type 2 diabetes – A study from India;Primary Care Diabetes;2024-04

3. The Principles of Insulin Management of Type 2 Diabetes Mellitus;Journal of Diabetes Mellitus;2023

4. Glucose-responsive nanoparticles designed via a molecular-docking-driven method for insulin delivery;Journal of Controlled Release;2022-12

5. Cost-effectiveness of insulin degludec/insulin aspart versus biphasic insulin aspart in Chinese population with type 2 diabetes;Frontiers in Public Health;2022-10-18